---
title: 'DTx in Belgium: It''s Time to Embed Digital Therapeutics in Clinical Pathways'
type: 'episode'
url: 'https://doc.social/episodes/dtx-in-belgium-its-time-to-embed-digital-therapeutics-in-clinical-pathways'
show: 'Faces of Digital Health'
show_url: 'https://doc.social/podcasts/faces-of-digital-health'
published: '2024-03-12'
audio: 'https://www.podtrac.com/pts/redirect.mp3/chrt.fm/track/3GF85E/traffic.megaphone.fm/DHT2343941375.mp3'
---

# DTx in Belgium: It's Time to Embed Digital Therapeutics in Clinical Pathways

## Summary

Did you know that Belgium has had an idea for classifying and validating digital therapeutics since 2018? A clear framework was formed with all main stakeholders involved - from health insurance to the industry. So why are we not hearing more about DTx in Belgium? In this discussion you will hear from Dr. Steven Vandeput - he is the Advisor for Digital MedTech and Services & Technologies Home Assistance in Belgium; he is managing the mHealthBelgium portal and, since 2019, has been a representative for beMedTech, the sector federation that represents the industry of medical technologies in Belgium.

Website: www.facesofdigitalhealth.com

Newsletter: https://fodh.substack.com/

Show notes:

00:00 - Introduction

01:45 - Digital Therapeutics in Belgium

03:50 - Belgium's Healthcare Framework Development

06:00 - The Validation Pyramid and Reimbursement System

08:00 - Fate of Pilot Projects and Their Impact

10:00 - Utilization of mHealth Belgium Portal

12:00 - Challenges in Reimbursement and Financing

14:00 - Prospects for Digital Therapeutic Companies

16:00 - Belgium's Approach to Financing Digital Health

18:00 - Anticipations for the Digital Health Field

20:00 - The Evolving European Frameworks

22:00 - Impact of Political Decisions and Healthcare System Integration

24:00 - The Future of mHealth Belgium Platform